marsh & mclennan cos. inc. - MMC
MMC
Close Chg Chg %
184.69 0.84 0.45%
Open Market
185.53
+0.84 (0.45%)
Volume: 1.18M
Last Updated:
Dec 22, 2025, 2:36 PM EDT
Company Overview: marsh & mclennan cos. inc. - MMC
MMC Key Data
| Open $184.76 | Day Range 184.43 - 186.42 |
| 52 Week Range 174.18 - 248.00 | Market Cap $90.49B |
| Shares Outstanding 489.91M | Public Float 489.50M |
| Beta 0.75 | Rev. Per Employee N/A |
| P/E Ratio 22.15 | EPS $8.39 |
| Yield 185.71% | Dividend $0.90 |
| EX-DIVIDEND DATE Oct 2, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 3.02M |
MMC Performance
| 1 Week | -0.81% | ||
| 1 Month | 2.09% | ||
| 3 Months | -6.14% | ||
| 1 Year | -12.77% | ||
| 5 Years | 60.43% |
MMC Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
27
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 211.286 | |
| Number of Ratings | 27 | Current Quarters Estimate | 1.98 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | 9.61 | |
| Last Quarter’s Earnings | 1.85 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 8.80 | Next Fiscal Year Estimate | 10.312 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 23 | 21 | 24 | 24 |
| Mean Estimate | 1.98 | 3.24 | 9.61 | 10.31 |
| High Estimates | 2.10 | 3.34 | 9.75 | 10.52 |
| Low Estimate | 1.92 | 3.16 | 9.50 | 10.00 |
| Coefficient of Variance | 1.81 | 1.44 | 0.51 | 1.24 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 6 | 5 | 5 |
| OVERWEIGHT | 3 | 3 | 1 |
| HOLD | 17 | 17 | 18 |
| UNDERWEIGHT | 1 | 1 | 0 |
| SELL | 0 | 0 | 2 |
| MEAN | Overweight | Hold | Hold |
SEC Filings for Marsh & Mclennan Cos. Inc. - MMC
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Marsh & Mclennan Cos. Inc. - MMC
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Aug 1, 2025 | Anthony K. Anderson Director | 1,500 | Open market or private purchase of non-derivative security Non-derivative transaction at $202.2 per share | 303,300.00 |
| Aug 1, 2025 | Anthony K. Anderson Director | 2,000 | Open market or private purchase of non-derivative security Non-derivative transaction at $201.02 per share | 402,040.00 |
| Apr 8, 2025 | Paul Beswick SVP, Chief Information Officer | 15,759 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $118.86 per share | 1,873,114.74 |
| Apr 8, 2025 | Paul Beswick SVP, Chief Information Officer | 13,522 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $246 per share | 3,326,412.00 |
| Apr 8, 2025 | Paul Beswick SVP, Chief Information Officer | 2,892 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 2, 2025 | Dean Michael Klisura President & CEO, Guy Carpenter | 30,504 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $83.05 per share | 2,533,357.20 |
| Apr 2, 2025 | Dean Michael Klisura President & CEO, Guy Carpenter | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 2, 2025 | Dean Michael Klisura President & CEO, Guy Carpenter | 20,935 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $245 per share | 5,129,075.00 |
| Mar 17, 2025 | Nicholas Mark Studer President and CEO of OWG | 41,660 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $83.05 per share | 3,459,863.00 |
| Mar 17, 2025 | Nicholas Mark Studer President and CEO of OWG | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 17, 2025 | Nicholas Mark Studer President and CEO of OWG | 77,719 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $200.47 per share | 15,580,327.93 |
| Mar 17, 2025 | Nicholas Mark Studer President and CEO of OWG | 73,703 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $164.14 per share | 12,097,610.42 |
| Mar 17, 2025 | Nicholas Mark Studer President and CEO of OWG | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 17, 2025 | Nicholas Mark Studer President and CEO of OWG | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 17, 2025 | Nicholas Mark Studer President and CEO of OWG | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 17, 2025 | Nicholas Mark Studer President and CEO of OWG | 28,329 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $230.16 per share | 6,520,202.64 |
| Mar 17, 2025 | Nicholas Mark Studer President and CEO of OWG | 20,132 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $57.32 per share | 1,153,966.24 |
| Mar 17, 2025 | Nicholas Mark Studer President and CEO of OWG | 46,147 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $90.78 per share | 4,189,224.66 |
| Mar 17, 2025 | Nicholas Mark Studer President and CEO of OWG | 30,292 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $73.2 per share | 2,217,374.40 |
| Mar 17, 2025 | Nicholas Mark Studer President and CEO of OWG | 50,417 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $117.53 per share | 5,925,510.01 |
Marsh & Mclennan Cos. Inc. in the News
Warren Buffett's Berkshire Hathaway shakes up investment holdings
Warren Buffett's Berkshire Hathaway cut back on financial, energy and drug stocks but beefed up its grocery and wireless holdings while adding an insurer.